Drugs Made In America Acquisition (DMII) Net Cash Flow (2025)
Drugs Made In America Acquisition (DMII) reported Net Cash Flow of -$314864.0 for Q4 2025.
Drugs Made In America Acquisition (DMII) Net Cash Flow (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Net Cash Flow data on file, last reported at -$314864.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 378,972.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -32,793.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -369,667.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 165,329.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -72,157.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -208,889.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -16.06 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 328,760.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -204,942.00 |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | -314,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |